相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism A Randomized Trial
Benjamin Planquette et al.
CHEST (2022)
Impact of bariatric surgery on oral anticoagulants pharmacology, and consequences for clinical practice: a narrative review
Cyril Leven et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2021)
Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparin
Sandip H. Patel et al.
CANCER (2021)
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study
Walter Ageno et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER)
David Spirk et al.
THROMBOSIS AND HAEMOSTASIS (2021)
Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies
Andrew W. Swartz et al.
ONCOLOGIST (2021)
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman et al.
BLOOD ADVANCES (2021)
Venous thromboembolism in cancer patients: a population-based cohort study
F. Mulder et al.
BLOOD (2021)
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism
Melina Verso et al.
EUROPEAN JOURNAL OF CANCER (2021)
Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study
Maria Cristina Vedovati et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysis
Lucia Caiano et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation
Karlyn A. Martin et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy
Tzu-Fei Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Bleeding in Patients With Gastrointestinal Cancer Compared With Nongastrointestinal Cancer Treated With Apixaban, Rivaroxaban, or Enoxaparin for Acute Venous Thromboembolism
Damon E. Houghton et al.
MAYO CLINIC PROCEEDINGS (2021)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Clinical implications of incidental venous thromboembolism in cancer patients
Frits Mulder et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial
Robert D. McBane et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m)
Andrea Marshall et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism
Robert A. Schmidt et al.
THROMBOSIS RESEARCH (2020)
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis
Frits Mulder et al.
BLOOD (2020)
l A Meta-Analysis of Case Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding in Patients with Cancer
Alym Abdulla et al.
THROMBOSIS AND HAEMOSTASIS (2020)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review
Allen Li et al.
THROMBOSIS RESEARCH (2020)
Management of heavy menstrual bleeding on anticoagulation
Bethany Samuelson Bannow
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
Intracranial hemorrhage with direct oral anticoagulants in patients with brain metastases
Avi Leader et al.
BLOOD ADVANCES (2020)
Drug-Drug Interactions of 257 Antineoplastic and Supportive Care Agents With 7 Anticoagulants: A Comprehensive Review of Interactions and Mechanisms
Erique Jose F. Peixoto de Miranda et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2020)
Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors
B. J. Carney et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Clinically relevant bleeding in cancer patients treated for venous thromboembolism from the CATCH study
P. . W. Kamphuisen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH
B. T. Samuelson Bannow et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)
G. A. Davies et al.
THROMBOSIS RESEARCH (2018)
Comparison of Nine Tools for Screening Drug-Drug Interactions of Oral Oncolytics
Lauren A. Marcath et al.
Journal of Oncology Practice (2018)
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study
Noemie Kraaijpoel et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Treatment algorithm in cancer-associated thrombosis: Canadian expert consensus
M. Carrier et al.
CURRENT ONCOLOGY (2018)
Cancer-Associated Venous Thromboembolic Disease, Version 2.2018 Featured Updates to the NCCN Guidelines
Michael B. Streiff et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review
Bethany R. Samuelson Bannow et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2018)
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
J. I. Weitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study
Luis Jara-Palomares et al.
THROMBOSIS RESEARCH (2017)
Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism
Richard Godin et al.
VASCULAR PHARMACOLOGY (2017)
Drug Interaction Database Sensitivity With Oral Antineoplastics: An Exploratory Analysis
John B. Bossaer et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment
J. C. Easaw et al.
CURRENT ONCOLOGY (2015)
Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer A Randomized Clinical Trial
Agnes Y. Y. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
Gary H. Lyman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12months: the DALTECAN Study
C. W. Francis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients
Aurelien Delluc et al.
THROMBOSIS RESEARCH (2015)
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study
Cheng E. Chee et al.
BLOOD (2014)
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis
Sam Schulman et al.
CIRCULATION (2014)
Efficacy and Safety of Anticoagulant Therapy for the Treatment of Acute Cancer-Associated Thrombosis: A Systematic Review and Meta-Analysis
Marc Carrier et al.
THROMBOSIS RESEARCH (2014)
Apixaban for Extended Treatment of Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism
Harry R. Bueller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Parenteral Anticoagulants Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
David A. Garcia et al.
CHEST (2012)
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
Harry R. Buller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
Freesia Horsted et al.
PLOS MEDICINE (2012)
Risk of Upper Gastrointestinal Bleeding With Low-Dose Acetylsalicylic Acid Alone and in Combination With Clopidogrel and Other Medications
Luis A. Garcia Rodriguez et al.
CIRCULATION (2011)
Low Doses of Acetylsalicylic Acid Increase Risk of Gastrointestinal Bleeding in a Meta-Analysis
Angel Lanas et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Oral Rivaroxaban for Symptomatic Venous Thromboembolism.
Rupert Bauersachs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.
Sam Schulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Alok A. Khorana et al.
CANCER (2007)
A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)
M. J. Kovacs et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer
Russell D. Hull et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Secondary prevention of venous thromboembolic events in patients with active cancer: Enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period
Steven R. Deitcher et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2006)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)
Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer - A randomized controlled study
G Meyer et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes
RC Becker et al.
AMERICAN HEART JOURNAL (2002)
Prognosis of cancers associated with venous thromboembolism.
HT Sorensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
